Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14317 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Barbara E Stähli und 59 weiteren Autor:innen. Beteiligte Einrichtung: University Heart Center, Department of Cardiology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Takotsubo Cardiomyopathy, Registries, Troponin T. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Abbott Vascular, Biotronik, Iten-Kohaut Foundation.
Abstract (Originalsprache)
Background
The clinical relevance of cardiac troponin (cTn) elevation in takotsubo syndrome (TTS) remains uncertain. The present study sought to investigate the role of cardiac troponin (cTn) elevations in mortality prediction of patients with Takotsubo syndrome (TTS).
Methods
Patients enrolled in the International Takotsubo (InterTAK) Registry from January 2011 to February 2020 with available data on peak cTn levels were included in the analysis. Peak cTn levels during the index hospitalization were used to define clinically relevant myocardial injury. The threshold at which clinically relevant myocardial injury drives mortality at 1 year was identified using restricted cubic spline analysis.
Results
Out of 2′938 patients, 222 (7.6%) patients died during 1‐year follow‐up. A more than 28.8‐fold increase of cTn above the upper reference limit was identified as threshold for clinically relevant myocardial injury. The presence of clinically relevant myocardial injury was significantly associated with an increased risk of mortality at 5 years (adjusted HR 1.58, 95% CI 1.18–2.12, p =.002). Clinically relevant myocardial injury was related to an increased 5‐year mortality risk in patients with apical TTS (adjusted HR 1.57, 95% CI 1.21–2.03, p =.001), in presence of physical stressors (adjusted HR 1.60, 95% CI 1.22–2.11, p =.001), and in absence of emotional stressors (adjusted HR 1.49, 95% CI, 1.17–1.89, p =.001).
Conclusion
This study for the first time determined a troponin threshold for the identification of TTS patients at excess risk of mortality. These findings advance risk stratification in TTS and assist in identifying patients in need for close monitoring and follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Heart Center, Department of Cardiology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.
- Department of Cardiology, Deutsches Herzzentrum der Charité, Angiology and Intensive Care Medicine, Berlin, Germany.
- Hochgebirgsklinik, Medicine Campus Davos, Davos, Switzerland.
- Christine Kühne Center for Allergy Research and Education (CK-CARE), Medicine Campus Davos, Davos, Switzerland.
- Center of Translational and Experimental Cardiology, University Hospital Zurich, Zurich, Switzerland.
- Vascular Physiopathology Unit, IRCCS Neuromed, Pozzilli, Italy.
ORCID-Profile: Victor Schweiger, Marco Roffi
Förderung
- Abbott Vascular
- Biotronik
- Iten-Kohaut Foundation
- Medtronic Foundation
- MicroPort
- SMT
- Deutsches Zentrum für Herz-Kreislaufforschung
- Biss Davies Charitable Trust
Zitieren
APA
Stähli, B. E., Schindler, M., Schweiger, V., Cammann, V. L., Szawan, K. A., Niederseer, D., Würdinger, M., Schönberger, A., Schönberger, M., Koleva, I., Mercier, J. C., Petkova, V., Mayer, S., Citro, R., Vecchione, C., Bossone, E., Gili, S., Neuhaus, M., Franke, J., …, & Lairez, O. (2024). Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14317
Vancouver
Stähli BE, Schindler M, Schweiger V, Cammann VL, Szawan KA, Niederseer D, et al. Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14317
BibTeX
@article{Sthli2024,
author = {Stähli, Barbara E and Schindler, Matthias and Schweiger, Victor and Cammann, Victoria L and Szawan, Konrad A and Niederseer, David and Würdinger, Michael and Schönberger, Alexander and Schönberger, Maximilian and Koleva, Iva and Mercier, Julien C and Petkova, Vanya and Mayer, Silvia and Citro, Rodolfo and Vecchione, Carmine and Bossone, Eduardo and Gili, Sebastiano and Neuhaus, Michael and Franke, Jennifer and Meder, Benjamin and Jaguszewski, Miłosz and Noutsias, Michel and Knorr, Maike and Jansen, Thomas and D'Ascenzo, Fabrizio and Dichtl, Wolfgang and von Lewinski, Dirk and Burgdorf, Christof and Kherad, Behrouz and Tschöpe, Carsten and Sarcon, Annahita and Shinbane, Jerold and Rajan, Lawrence and Michels, Guido and Pfister, Roman and Cuneo, Alessandro and Jacobshagen, Claudius and Karakas, Mahir and Koenig, Wolfgang and Pott, Alexander and Meyer, Philippe and Roffi, Marco and Banning, Adrian and Wolfrum, Mathias and Cuculi, Florim and Kobza, Richard and Fischer, Thomas A and Vasankari, Tuija and Airaksinen, K E Juhani and Napp, L Christian and Dworakowski, Rafal and MacCarthy, Philip and Kaiser, Christoph and Osswald, Stefan and Galiuto, Leonarda and Chan, Christina and Bridgman, Paul and Beug, Daniel and Delmas, Clément and Lairez, Olivier},
title = {Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14317}
}
EUVIMED